At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BLLN BillionToOne, Inc.
Trading 10-20 14:17:50 EDT
104.18
+3.15
+3.12%
High104.47Low99.55Vol163.90K
Open101.12D1 Closing101.03Amplitude4.87%
Mkt Cap4.92BTradable Cap3.00BTotal Shares47.19M
T/O16.89MT/O Rate0.57%Tradable Shares28.81M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

BillionToOne Chairman and CEO Oguzhan Atay Reports Disposal of $1.09 Million in Common Shares
Reuters  ·  10-17
BillionToOne Chairman and CEO Oguzhan Atay Reports Disposal of $1.09 Million in Common Shares
BillionToOne Chairman and CEO Oguzhan Atay Reports $1.82 Million Common Share Disposal
Reuters  ·  10-15
BillionToOne Chairman and CEO Oguzhan Atay Reports $1.82 Million Common Share Disposal
BillionToOne to Report Q3 2026 Results, Host Conference Call
Reuters  ·  10-14
BillionToOne to Report Q3 2026 Results, Host Conference Call
BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026
GlobeNewswire  ·  10-14
BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026
BillionToOne CTO David Tsao Disposes of 20,000 Common Shares for $2.11 Million
Reuters  ·  10-08
BillionToOne CTO David Tsao Disposes of 20,000 Common Shares for $2.11 Million
BillionToOne Study Finds Northstar Response Tissue-Free ctDNA Assay Matches or Beats Tumor-Informed Monitoring in Advanced Cancer Patients
Reuters  ·  10-07
BillionToOne Study Finds Northstar Response Tissue-Free ctDNA Assay Matches or Beats Tumor-Informed Monitoring in Advanced Cancer Patients
BillionToOne is Maintained at Buy by Guggenheim
Dow Jones  ·  10-01
BillionToOne is Maintained at Buy by Guggenheim
BillionToOne Chairman and CEO Oguzhan Atay Disposes of USD 1,328,656 in Class a Common Shares
Reuters  ·  10-01
BillionToOne Chairman and CEO Oguzhan Atay Disposes of USD 1,328,656 in Class a Common Shares
BillionToOne SVP of Laboratory Operations John Roderick Ten Bosch Disposes of 1,416 Common Shares Worth $169,920
Reuters  ·  09-29
BillionToOne SVP of Laboratory Operations John Roderick Ten Bosch Disposes of 1,416 Common Shares Worth $169,920
Billiontoone, Inc. : Piper Sandler Raises Target Price to $140 from $108
THOMSON REUTERS  ·  09-25
Billiontoone, Inc. : Piper Sandler Raises Target Price to $140 from $108
BillionToOne SVP Laboratory Operations John Roderick Ten Bosch Sells 1,416 Shares for $150,965.76
Reuters  ·  09-24
BillionToOne SVP Laboratory Operations John Roderick Ten Bosch Sells 1,416 Shares for $150,965.76
BillionToOne General Counsel Thomas P. Lynch Disposes of 35,112 Common Shares Worth USD 3.87 Million
Reuters  ·  09-22
BillionToOne General Counsel Thomas P. Lynch Disposes of 35,112 Common Shares Worth USD 3.87 Million
BillionToOne Chairman and CEO Oguzhan Atay Disposes of USD 2,637,450 Class a Common Shares
Reuters  ·  09-17
BillionToOne Chairman and CEO Oguzhan Atay Disposes of USD 2,637,450 Class a Common Shares
BillionToOne General Counsel Thomas P. Lynch Sells 19,962 Class a Shares for $1.99 Million
Reuters  ·  09-11
BillionToOne General Counsel Thomas P. Lynch Sells 19,962 Class a Shares for $1.99 Million
BillionToOne Management to Join Wells Fargo Annual Healthcare Conference Fireside Chat
Reuters  ·  09-03
BillionToOne Management to Join Wells Fargo Annual Healthcare Conference Fireside Chat
Canaccord Genuity Initiates BillionToOne at Buy With $120 Price Target
MT Newswires Live  ·  09-02
Canaccord Genuity Initiates BillionToOne at Buy With $120 Price Target
BillionToOne Launches New Liquid Biopsy Test to Help Identify Tissue of Origin
MT Newswires Live  ·  09-01
BillionToOne Launches New Liquid Biopsy Test to Help Identify Tissue of Origin
BillionToOne announces the launch of Northstar Origin
TIPRANKS  ·  09-01
BillionToOne announces the launch of Northstar Origin
BillionToOne SVP Laboratory Operations John Roderick Ten Bosch Sells 1,417 Class a Shares for $141,700
Reuters  ·  08-28
BillionToOne SVP Laboratory Operations John Roderick Ten Bosch Sells 1,417 Class a Shares for $141,700
BillionToOne announces publication of study on cfDNA fetal risk assessment
TIPRANKS  ·  08-19
BillionToOne announces publication of study on cfDNA fetal risk assessment

Introduction

Company Name.
BillionToOne, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
BillionToOne, Inc. began operations in 2016 as a Delaware corporation. The company developed a revolutionary single-molecule next-generation sequencing (smNGS) platform capable of detecting and precisely quantifying genetic targets at single-molecule sensitivity, powered by its patented Quantitative Counting Templates (QCT). This technology overcomes a critical bottleneck in healthcare by detecting sparse yet clinically significant disease signals in cell-free DNA. BillionToOne's platform has been successfully applied to a series of groundbreaking prenatal and oncology products that deliver actionable diagnostic information from a simple blood sample.
Issue price:
--